vs

Side-by-side financial comparison of First Foundation Inc. (FFWM) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $48.4M, roughly 1.0× First Foundation Inc.). MARAVAI LIFESCIENCES HOLDINGS, INC. runs the higher net margin — -71.6% vs -97.9%, a 26.3% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs -11.8%). MARAVAI LIFESCIENCES HOLDINGS, INC. produced more free cash flow last quarter ($-24.9M vs $-35.2M). Over the past eight quarters, First Foundation Inc.'s revenue compounded faster (-2.7% CAGR vs -11.9%).

John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

FFWM vs MRVI — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.0× larger
MRVI
$49.9M
$48.4M
FFWM
Growing faster (revenue YoY)
FFWM
FFWM
+433.5% gap
FFWM
421.7%
-11.8%
MRVI
Higher net margin
MRVI
MRVI
26.3% more per $
MRVI
-71.6%
-97.9%
FFWM
More free cash flow
MRVI
MRVI
$10.3M more FCF
MRVI
$-24.9M
$-35.2M
FFWM
Faster 2-yr revenue CAGR
FFWM
FFWM
Annualised
FFWM
-2.7%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FFWM
FFWM
MRVI
MRVI
Revenue
$48.4M
$49.9M
Net Profit
$-8.0M
$-35.7M
Gross Margin
25.8%
Operating Margin
-97.5%
-117.9%
Net Margin
-97.9%
-71.6%
Revenue YoY
421.7%
-11.8%
Net Profit YoY
43.0%
-37.7%
EPS (diluted)
$-0.09
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FFWM
FFWM
MRVI
MRVI
Q4 25
$48.4M
$49.9M
Q3 25
$63.6M
$41.6M
Q2 25
$51.4M
$47.4M
Q1 25
$71.4M
$46.9M
Q4 24
$9.3M
$56.6M
Q3 24
$9.2M
$69.0M
Q2 24
$57.5M
$69.4M
Q1 24
$51.1M
$64.2M
Net Profit
FFWM
FFWM
MRVI
MRVI
Q4 25
$-8.0M
$-35.7M
Q3 25
$-146.3M
$-25.6M
Q2 25
$-7.7M
$-39.6M
Q1 25
$6.9M
$-29.9M
Q4 24
$-14.1M
$-25.9M
Q3 24
$-82.2M
$-97.1M
Q2 24
$3.1M
$-9.8M
Q1 24
$793.0K
$-12.1M
Gross Margin
FFWM
FFWM
MRVI
MRVI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
FFWM
FFWM
MRVI
MRVI
Q4 25
-97.5%
-117.9%
Q3 25
-92.7%
-98.6%
Q2 25
-21.1%
-139.8%
Q1 25
8.8%
-104.9%
Q4 24
-247.7%
-66.7%
Q3 24
-1276.7%
-239.9%
Q2 24
4.6%
-19.4%
Q1 24
-0.2%
-29.4%
Net Margin
FFWM
FFWM
MRVI
MRVI
Q4 25
-97.9%
-71.6%
Q3 25
-230.1%
-61.4%
Q2 25
-15.0%
-83.5%
Q1 25
9.7%
-63.9%
Q4 24
-152.2%
-45.8%
Q3 24
-896.9%
-140.6%
Q2 24
5.4%
-14.1%
Q1 24
1.6%
-18.8%
EPS (diluted)
FFWM
FFWM
MRVI
MRVI
Q4 25
$-0.09
$-0.24
Q3 25
$-1.78
$-0.18
Q2 25
$-0.09
$-0.27
Q1 25
$0.08
$-0.21
Q4 24
$-0.24
$-0.21
Q3 24
$-1.23
$-0.68
Q2 24
$0.05
$-0.07
Q1 24
$0.01
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FFWM
FFWM
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$1.6B
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$912.6M
$212.4M
Total Assets
$11.9B
$770.6M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FFWM
FFWM
MRVI
MRVI
Q4 25
$1.6B
$216.9M
Q3 25
$1.7B
$243.6M
Q2 25
$1.1B
$269.9M
Q1 25
$1.0B
$285.1M
Q4 24
$1.0B
$322.4M
Q3 24
$1.1B
$578.2M
Q2 24
$1.4B
$573.2M
Q1 24
$1.6B
$561.7M
Total Debt
FFWM
FFWM
MRVI
MRVI
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
FFWM
FFWM
MRVI
MRVI
Q4 25
$912.6M
$212.4M
Q3 25
$917.9M
$245.4M
Q2 25
$1.1B
$265.9M
Q1 25
$1.1B
$300.6M
Q4 24
$1.1B
$325.3M
Q3 24
$1.1B
$344.9M
Q2 24
$933.2M
$434.7M
Q1 24
$928.7M
$410.7M
Total Assets
FFWM
FFWM
MRVI
MRVI
Q4 25
$11.9B
$770.6M
Q3 25
$11.9B
$849.2M
Q2 25
$11.6B
$897.0M
Q1 25
$12.6B
$959.8M
Q4 24
$12.6B
$1.0B
Q3 24
$13.4B
$1.3B
Q2 24
$13.7B
$1.4B
Q1 24
$13.6B
$1.4B
Debt / Equity
FFWM
FFWM
MRVI
MRVI
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FFWM
FFWM
MRVI
MRVI
Operating Cash FlowLast quarter
$-31.9M
$-22.8M
Free Cash FlowOCF − Capex
$-35.2M
$-24.9M
FCF MarginFCF / Revenue
-72.8%
-49.9%
Capex IntensityCapex / Revenue
6.9%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.9M
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FFWM
FFWM
MRVI
MRVI
Q4 25
$-31.9M
$-22.8M
Q3 25
$9.2M
$-15.2M
Q2 25
$-16.3M
$-10.3M
Q1 25
$-552.0K
$-9.4M
Q4 24
$-8.7M
$-14.6M
Q3 24
$14.2M
$13.1M
Q2 24
$-9.1M
$17.4M
Q1 24
$7.2M
$-8.5M
Free Cash Flow
FFWM
FFWM
MRVI
MRVI
Q4 25
$-35.2M
$-24.9M
Q3 25
$8.6M
$-18.1M
Q2 25
$-16.7M
$-13.1M
Q1 25
$-2.5M
$-14.6M
Q4 24
$-11.4M
$-20.5M
Q3 24
$13.4M
$4.5M
Q2 24
$-9.4M
$7.9M
Q1 24
$5.9M
$-14.1M
FCF Margin
FFWM
FFWM
MRVI
MRVI
Q4 25
-72.8%
-49.9%
Q3 25
13.5%
-43.4%
Q2 25
-32.4%
-27.7%
Q1 25
-3.5%
-31.2%
Q4 24
-123.5%
-36.2%
Q3 24
146.2%
6.6%
Q2 24
-16.3%
11.4%
Q1 24
11.6%
-22.0%
Capex Intensity
FFWM
FFWM
MRVI
MRVI
Q4 25
6.9%
4.2%
Q3 25
1.0%
7.0%
Q2 25
0.8%
6.1%
Q1 25
2.8%
11.2%
Q4 24
29.4%
10.3%
Q3 24
9.0%
12.4%
Q2 24
0.4%
13.8%
Q1 24
2.5%
8.8%
Cash Conversion
FFWM
FFWM
MRVI
MRVI
Q4 25
Q3 25
Q2 25
Q1 25
-0.08×
Q4 24
Q3 24
Q2 24
-2.96×
Q1 24
9.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FFWM
FFWM

Segment breakdown not available.

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons